EUVIMEDEUVIMED entdecken
Crossref

Tumoral PD-L1 Expression as a Prognostic Marker in Invasive Cervical Cancer

Carolin Schröder, Maryam Qureischi, Thomas Hecking, Jennifer Nadal, Seher Aktekin, Laura Tascón Padrón, Eva K Egger, Glen Kristiansen, Thore Thiesler, Alexander Mustea

Anticancer Research · 2026-08 · 46 (8) · 4371-4383

DOI: 10.21873/anticanres.18294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.07.2026. Verfasst von Carolin Schröder und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Gynaecological Oncology, University Hospital Bonn, Bonn, Germany; carolin.schroeder@ukbonn.de. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, B7-H1 Antigen, Biomarkers, Tumor.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsB7-H1 AntigenBiomarkers, TumorHumansFemalePrognosisMiddle AgedRetrospective StudiesAdultAgedNeoplasm InvasivenessImmunohistochemistryNeoplasm Staging

Stichwörter der Autor:innen

CPSCervical cancerPD-L1TPSoverall survivalprognostic factorprogression-free survival

Substanzen

B7-H1 AntigenBiomarkers, TumorCD274 protein, human

Autor:innen und Institutionen

  • Department of Gynaecology and Gynaecological Oncology, University Hospital Bonn, Bonn, Germany; carolin.schroeder@ukbonn.de.
  • Department of Gynaecology and Obstetrics, St. Josef, Troisdorf, Germany.
  • Gynaecological Outpatient Clinic Friedensplatz, Bonn, Germany.
  • Department of Medical Biometry, Informatics and Epidemiology, Faculty of Medicine, University Hospital Bonn, Bonn, Germany.
  • Department of Pathology, University Hospital Bonn, Germany.
  • Department of Gynaecology and Gynaecological Oncology, University Hospital Bonn, Bonn, Germany.

Zitieren

APA

Schröder, C., Qureischi, M., Hecking, T., Nadal, J., Aktekin, S., Padrón, L. T., Egger, E. K., Kristiansen, G., Thiesler, T., & Mustea, A. (2026). Tumoral PD-L1 Expression as a Prognostic Marker in Invasive Cervical Cancer. Anticancer Research, 46(8), 4371-4383. https://doi.org/10.21873/anticanres.18294

Vancouver

Schröder C, Qureischi M, Hecking T, Nadal J, Aktekin S, Padrón LT, et al. Tumoral PD-L1 Expression as a Prognostic Marker in Invasive Cervical Cancer. Anticancer Research. 2026;46(8):4371-4383. doi:10.21873/anticanres.18294

BibTeX
@article{Schrder2026,
  author = {Schröder, Carolin and Qureischi, Maryam and Hecking, Thomas and Nadal, Jennifer and Aktekin, Seher and Padrón, Laura Tascón and Egger, Eva K and Kristiansen, Glen and Thiesler, Thore and Mustea, Alexander},
  title = {Tumoral PD-L1 Expression as a Prognostic Marker in Invasive Cervical Cancer},
  journal = {Anticancer Research},
  year = {2026},
  volume = {46},
  number = {8},
  pages = {4371--4383},
  doi = {10.21873/anticanres.18294}
}
Kostenlos starten →